Prognosis
Astra-Oxford Vaccine Works But Doses Could Be in Short Supply
- Ramping up production has been a challenge for U.K. partners
- World needs as many vaccines as it can get, Astra says
Photographer: Eva Marie Uzcategui/Bloomberg
This article is for subscribers only.
Let the scramble for doses begin.
AstraZeneca Plc and the University of Oxford followed Moderna Inc. and Pfizer Inc. in announcing that their Covid-19 vaccine appears to work. Though the U.K. partners’ data don’t look quite as sparkling, regulators could clear any of the shots for emergency use in coming weeks.